HeartBeam Arrhythmia Assessment System Earns FDA Clearance
HeartBeam announced that the FDA has granted 510(k) clearance of the HeartBeam system for comprehensive arrhythmia assessment.
Read MoreDec 16, 2024 | Clearances | 0 |
HeartBeam announced that the FDA has granted 510(k) clearance of the HeartBeam system for comprehensive arrhythmia assessment.
Read MoreMay 31, 2023 | Company News, Remote Monitoring | 0 |
HeartBeam has received a patent relating to the initial AI capability in the form of an expert system for its HeartBeam AIMIGo System.
Read MoreMar 15, 2023 | Remote Monitoring | 0 |
The acquisition extends HeartBeam’s reach in remote monitoring and detection with full ownership of an existing FDA-cleared product.
Read MoreOct 7, 2022 | Remote Monitoring | 0 |
HeartBeam announced the expansion of its product portfolio pipeline to serve the growing cardiac device wearable technology market.
Read MoreAug 16, 2022 | Company News | 0 |
HeartBeam submitted a 510(k) application to the U.S. FDA for its HeartBeam AIMI platform technology for use in diagnosing heart attacks.
Read More